Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Mol Genet Metab. 2017 Jul 12;122(1-2):51–59. doi: 10.1016/j.ymgme.2017.07.003

Figure 3. Effect of anaplerotic therapy on the urinary excretion of methylcitrate (A), 3-hydroxy-propionate (B), propionylglycine (C), and ketone bodies (sum of 30hydroxybutyric acid and acetoacetate) (D) in patients with propionic acidemia.

Figure 3

Each value is the average ± SD of at least 12 observations. There were no statistically significant difference between any treatment and baseline.